Why do you feel stupid? 4,000,000 shares of its common stock were sold recently to more sophisticated investors than you or me at a price of $11.40 per share. Institutional interest is increasing. ASCO may provide a boost, otherwise simply wait for the result. The later the better. As I have noted many many times the market is completely discounting anything other than NLNKs lead product.
Blud, the general index's are up but the BTK / biotech index is down about 1/2 %. That being said very few speculators seem interested in buying before the first interim data / I take this to mean there is little expectation among investors that the trial will be stopped at that time. If they are correct other than additional survival data from the phase2 panc trial which may or may not be disclosed at ASCO . We may have several months to wait for the second interim look or up to nine months for the trial to end for the outcome of the Phase 3 trial to find out if you're stupid or brilliant.